Negative symptoms and cognitive impairment are associated with distinct motivational deficits in treatment resistant schizophrenia
Open accessPublished version of a preprint
Abstract
Background: Motivational deficits are a central feature of the negative syndrome in schizophrenia. They have consistently been associated with reduced willingness to expend physical effort in return for monetary rewards on effort based decision making (EBDM) paradigms. Nevertheless, the mechanisms underlying such altered performance are not well characterised, and it remains unclear if they are driven purely by negative symptoms, or also in part by cognitive impairment, antipsychotic treatment or even positive symptoms. Here we investigated the impact of all these factors using a paradigm that has not previously been used to measure EBDM in schizophrenia. Methods: Forty treatment resistant schizophrenia (TRS) patients on clozapine and matched controls (N = 80) completed a well validated EBDM task which offers monetary rewards in return for physical effort. Choice and reaction time data was analysed using logistic regressions, as well as Bayesian hierarchical drift diffusion modelling (HDDM). Behavioural parameters were compared between groups and their association with negative symptoms, cognitive function and serum clozapine levels were assessed. Results: Overall, TRS patients accepted significantly less offers than controls during effort-based decision making, suggesting they were less motivated. They demonstrated reduced sensitivity to increasing rewards, but surprisingly were also less averse to increasing effort. Despite a positive correlation between negative symptoms and cognitive function in TRS, reward sensitivity was associated only with cognitive performance. In contrast, reduced effort aversion correlated with negative symptom severity. Clozapine levels and positive symptoms were not associated with either behavioural parameter. Conclusion: Motivational deficits in TRS are characterised by both diminished reward sensitivity and reduced effort aversion during EBDM. Cognitive dysfunction and negative symptom severity account for distinct aspects of these behavioural changes, despite positive associations between themselves. Overall, these findings demonstrate that negative symptoms and cognitive impairment have significant independent contributions to EBDM in TRS, thereby opening the possibility of individualised treatment targeting these mechanisms to improve motivation.
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
Insensitivity to reward has been shown across all stages of schizophrenia and has been associated with negative symptoms, especially anhedonia, and cognitive deficits.
“Insensitivity to reward has been shown across all stages of schizophrenia and has been associated with negative symptoms, especially anhedonia, and cognitive deficits.55,61,119,120”
From Investigating disorder-specific and transdiagnostic alterations in model-based and model-free decision-making (2024) · cites this paper as [120]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Cites
Keefe, R. (2004) · Schizophrenia Research · doi:10.1016/j.schres.2003.09.011 · Cited by 1,573 · see citing works
The clinical assessment interview for negative symptoms (CAINS): Final development and validation
Kring, A. M., Gur, R. E., Blanchard, J. J., Horan, W. P., & Reise, S. P. (2013) · American Journal of Psychiatry · doi:10.1176/appi.ajp.2012.12010109 · Cited by 726 · see citing works
The global cognitive impairment in schizophrenia: consistent over decades and around the world
Schaefer, J., Giangrande, E., Weinberger, D. R., & Dickinson, D. (2013) · Schizophrenia Research · doi:10.1016/j.schres.2013.07.009 · Cited by 605 · see citing works
The anatomy of apathy: a neurocognitive framework for amotivated behaviour
Le Heron, C., Apps., M. A. J., & Husain, M. (2018) · Neuropsychologia · doi:10.1016/j.neuropsychologia.2017.07.003 · Cited by 380 · cited 1× · see citing works
“One example is the process of option selection, where participants are asked to weigh up the bene fi ts (e.g., potential reward) and costs (e.g., effort required to obtain that reward) of a decision prior to initiating goal-directed action [18, 20, 21].”
BackgroundSelf-citationIndividual Differences in Premotor Brain Systems Underlie Behavioral Apathy
Bonnelle, V., Manohar, S., Behrens, T., & Husain, M. (2015) · Cerebral Cortex · doi:10.1093/cercor/bhv247 · Cited by 163 · see citing works
Self-citationImagining the future: degraded representations of future rewards and events in schizophrenia
Heerey, E. A., Matveeva, T. M., & Gold, J. M. (2011) · Journal of Abnormal Psychology · doi:10.1037/a0021810 · Cited by 78 · see citing works
Flagged first, then by citations
Cited by
Sorted by citations
Knolle, F., Sen, P., Culbreth, A., Koch, K., Schmitz-Koep, B., Gürsel, D. A., Wunderlich, K., Avram, M., Berberich, G., Sorg, C., et al. (2024) · Journal of Psychiatry and Neuroscience · doi:10.1503/jpn.240020 · Cited by 9 · see citing works
- Authors
- Saleh, Y., Jarratt-Barnham, I., Petitet, P., Fernandez-Egea, E., Manohar, S. G., & Husain, M.
- Affiliations
- John Radcliffe Hospital (GB)
- Lyon 1 Université (FR)
- Corresponding author
- Saleh, Y.
- Venue
- Molecular Psychiatry
- Published
- 2023-08-25
- Volume
- 28
- Issue
- 11
- Pages
- 4831-4841
- ISSN
- 1359-4184 (ISSN-L)
- 1476-5578
- PMC
- PMC10914595
- OpenAlex
- W4386162763
- Cited by
- 45
- References
- 6
- Citations by year
- 2026: 10 · 2025: 21 · 2024: 13 · 2022: 1
- FWCI
- 8.96
- Type
- journal article
- Language
- en
- Open access
- hybrid
- doi.org
- Locations
- Molecular Psychiatry (publishedVersion, cc-by)
- Research Square (acceptedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- Apollo (University of Cambridge) (submittedVersion, cc-by)
- Funders
- Wellcome Trust (206330/Z/17/Z)
- Topics
- Health Sciences › Medicine › Psychiatry and Mental health › Schizophrenia research and treatment
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Neurotransmitter Receptor Influence on Behavior
- Life Sciences › Neuroscience › Cognitive Neuroscience › Neural and Behavioral Psychology Studies
- Keywords
- treatment-resistant schizophrenia, negative symptoms, cognitive impairment, motivational deficits, effort-based decision making, reward sensitivity, effort aversion, clozapine, positive symptoms
- MeSH terms
- Schizophrenia, Treatment-Resistant, Bayes Theorem, Clozapine, Decision Making, Humans, Motivation, Reward, Schizophrenia, Cognitive Dysfunction
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review